Follow the BioSyent Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares trade on the CA market, under the supervision of SEDI. Operating in the Health Care sector, BioSyent Inc. has logged 77 insider filings. Market capitalisation: €180.4m. The latest transaction was disclosed on 28 August 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: BioSyent Inc.. Every trade is openly available.
77
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioSyent Inc. Strong Buy (bullish), based on 1 analysts. Average price target: CA$18.00.
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,122 of 29,056 companies
73.1
score / 100
Value
57
Quality
89
FCF yld4.8%
Earn yld5.1%
EV/EBITDA13.8x
ROE24%
Gross mgn77%
Net mgn21%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
BioSyent Inc. es una empresa canadiense centrada en el desarrollo y la comercialización de productos farmacéuticos. Su objetivo es proporcionar soluciones innovadoras para mejorar la salud de los pacientes.